| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |